TY  - CONF

T1  - Randomized trial of two intravenous schedules of the topoisomerase I inhibitor liposomal lurtotecan in women with relapsed epithelial ovarian cancer: A trial of the National Cancer Institute of Canada Clinical Trials Group

JO  - JOURNAL OF CLINICAL ONCOLOGY

PY  - 2005/03/20

AU  - Dark GG

AU  - Calvert AH

AU  - Grimshaw R

AU  - Poole C

AU  - Swenerton K

AU  - Kaye S

AU  - Coleman R

AU  - Jayson G

AU  - Le T

AU  - Ellard S

AU  - Trudeau M et al

ED  - 

DO  - DOI: 10.1200/JCO.2005.02.028

VL  - 23

IS  - 9

SP  - 1859

EP  - 1866

Y2  - 2025/10/10

ER  -